| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exelixis, Inc. (EXEL) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. EXEL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.96M | $104.55M | - | |
| Dir | 1.55M | $82.66M | - | |
| Dir | 1.19M | $63.28M | - | |
| CFO | 1.12M | $59.46M | - | |
| VP | 594.7K | $31.65M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 15, 2017 | Schwab Gisela67 | Pres Prod Dev &Med Aff &CMO | Sale+OE | 50,007 | $22.53 | $1,126,657.71 | -24.0% | |
| Mar 15, 2017 | Willsey Lance | Director | Sale+OE | 10,000 | $22.86 | $228,600.00 | -1.7% | |
| Mar 13, 2017 | Cohen Charles | Director | Sell | 10,000 | $21.82 | $218,200.00 | -4.0% | |
| Mar 10, 2017 | Marchesi Vincent T | Director | Sale+OE | 40,000 | $21.98 | $879,200.00 | -25.0% | |
| Mar 6, 2017 | Morrissey Michael | President And CEO | Sale+OE | 200,000 | $22.72 | $4,544,000.00 | -62.5% | |
| Mar 3, 2017 | Hessekiel Jeffrey54 | EVP And General Counsel | Sale+OE | 100,000 | $23.04 | $2,303,677.90 | -10.4% | |
| Mar 3, 2017 | Haley Patrick J.56 | Sr. Vice President, Commercial | Sell | 2,500 | $23.04 | $57,600.00 | -2.3% |